Advanced Biomedical Technologies (ABMT) Stock Price

Advanced Biomedical Technologies Price

OTC·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

For Advanced Biomedical Technologies, the net margin of -543.7% is up versus -8,109.4% a few years ago. The stock trades about 400% above its 52-week low.

Advanced Biomedical Technologies stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Advanced Biomedical Technologies over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Advanced Biomedical Technologies stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Advanced Biomedical Technologies's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Advanced Biomedical Technologies Stock Price History
DateAdvanced Biomedical Technologies Price
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/3/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/19/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
8/13/20250.00 USD
8/12/20250.00 USD
8/11/20250.00 USD
8/8/20250.00 USD
8/7/20250.00 USD
8/6/20250.00 USD
8/5/20250.00 USD
8/4/20250.00 USD
8/1/20250.00 USD
7/31/20250.00 USD
7/30/20250.00 USD
7/29/20250.00 USD
7/28/20250.00 USD
7/25/20250.00 USD
7/24/20250.00 USD
7/23/20250.00 USD
7/22/20250.00 USD
7/21/20250.00 USD
7/18/20250.00 USD
7/17/20250.00 USD
7/16/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

Advanced Biomedical Technologies Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2013
0.00 USD
-617,800.00 USD
-827,800.00 USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
-605,200.00 USD
-862,900.00 USD
Jan 1, 2016
0.00 USD
-461,300.00 USD
-724,700.00 USD
Jan 1, 2017
0.00 USD
-403,600.00 USD
-691,600.00 USD
Jan 1, 2018
0.00 USD
-634,000.00 USD
-953,300.00 USD
Jan 1, 2019
11,700.00 USD
-604,700.00 USD
-948,800.00 USD
Jan 1, 2020
123,600.00 USD
-446,600.00 USD
-672,000.00 USD

Advanced Biomedical Technologies Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 11:19 AM
 
SHARESM
20072008200920102011201220132014201520162017201820192020
55.1150.5154.7655.8656.4256.5656.8769.9456.8766.6968.2869.3869.6369.94
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Advanced Biomedical Technologies generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Advanced Biomedical Technologies retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Advanced Biomedical Technologies's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Advanced Biomedical Technologies has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Advanced Biomedical Technologies's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Advanced Biomedical Technologies stock margins

The Advanced Biomedical Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Advanced Biomedical Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Advanced Biomedical Technologies.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2013
58.09 %
- %
- %
Jan 1, 2014
58.09 %
0.00 %
0.00 %
Jan 1, 2015
58.09 %
- %
- %
Jan 1, 2016
58.09 %
- %
- %
Jan 1, 2017
58.09 %
- %
- %
Jan 1, 2018
58.09 %
- %
- %
Jan 1, 2019
35.04 %
-5,168.38 %
-8,109.40 %
Jan 1, 2020
58.09 %
-361.33 %
-543.69 %

Advanced Biomedical Technologies Stock Revenue, EBIT, Earnings per Share

The Advanced Biomedical Technologies earnings per share therefore indicates how much revenue Advanced Biomedical Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2013
0.00 USD
-0.01 USD
-0.01 USD
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
-0.01 USD
-0.02 USD
Jan 1, 2016
0.00 USD
-0.01 USD
-0.01 USD
Jan 1, 2017
0.00 USD
-0.01 USD
-0.01 USD
Jan 1, 2018
0.00 USD
-0.01 USD
-0.01 USD
Jan 1, 2019
0.00 USD
-0.01 USD
-0.01 USD
Jan 1, 2020
0.00 USD
-0.01 USD
-0.01 USD

Advanced Biomedical Technologies business model & stock analysis

Advanced Biomedical Technologies Inc is an innovative biomedical company specializing in the development of advanced medical devices and technologies. The company was founded in 1985 by an experienced team of biotech experts and is headquartered in California, USA. History: The company's roots lie in the research and development of novel medical implants and prosthetics. However, over the years, the company has quickly evolved into a leading provider of medical devices and technologies in the fields of diagnostics, therapy, and care. Business model: The business model of Advanced Biomedical Technologies Inc is focused on providing innovative and advanced solutions for medical care. The company strives to continuously develop its products and help customers achieve their healthcare goals. Divisions: The company is divided into four main divisions focusing on different medical areas: 1) Interventional Cardiology: Here, the company develops devices for the treatment of heart diseases, such as stents for reopening narrowed vessels. 2) Orthopedics: Another focus is on the development of innovative orthopedic implants and prosthetics that help patients regain their mobility and improve their quality of life. 3) Oncology: In this division, the company works on the development of medical devices and systems for the diagnosis and treatment of cancer. 4) Neurology: Here, the company focuses on the development of medical technologies and devices for the diagnosis and treatment of nervous system disorders, such as Parkinson's or Alzheimer's. Products: Advanced Biomedical Technologies Inc's products include a variety of medical devices and technologies specialized in different medical areas. Some of the company's most well-known products are: - Stents for reopening narrowed vessels in the heart - Artificial joints and implants for restoring mobility and quality of life - Medical devices for the diagnosis and treatment of cancer - Neurostimulation devices for the treatment of chronic pain and other neurological disorders - Robot-assisted surgery systems that assist surgeons in complex procedures. Conclusion: Advanced Biomedical Technologies Inc is a leading biomedical company specializing in the development of advanced medical devices and technologies. The company has a long history in the research and development of medical implants and prosthetics but has quickly expanded into a broader range of medical applications. With its focus on developing innovative products for patients' quality of life, Advanced Biomedical Technologies Inc will continue to play an important role in medical innovation.

Advanced Biomedical Technologies SWOT Analysis

Strengths

Advanced Biomedical Technologies Inc has a strong reputation in the biomedical industry due to its innovative products and advanced technologies.

The company has a talented team of researchers and scientists who consistently deliver high-quality results.

Advanced Biomedical Technologies Inc has established strong partnerships with leading universities and research institutions, allowing access to cutting-edge research and expertise.

Weaknesses

The company heavily relies on external funding for its research and development projects, making it vulnerable to funding fluctuations.

Advanced Biomedical Technologies Inc has a relatively small market share compared to its larger competitors, limiting its bargaining power and market influence.

The company currently lacks a diverse product portfolio, which may hinder its ability to capitalize on multiple market segments.

Opportunities

The growing demand for advanced medical technologies presents a significant opportunity for Advanced Biomedical Technologies Inc to expand its market presence.

Advancements in 3D printing and other emerging technologies provide potential avenues for the development of new and innovative products.

The increasing focus on personalized medicine creates an opportunity for Advanced Biomedical Technologies Inc to develop customized solutions for individual patients.

Threats

Intense competition from larger and more established companies poses a threat to Advanced Biomedical Technologies Inc's market position.

Changes in regulatory policies and compliance requirements may impact the company's ability to bring products to market efficiently.

Global economic uncertainties and fluctuations in currency exchange rates could affect the company's financial stability and international operations.

Advanced Biomedical Technologies Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Advanced Biomedical Technologies historical P/E ratio, EBIT multiple, and P/S ratio

Advanced Biomedical Technologies annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Advanced Biomedical Technologies shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2013
56.87 M Stocks
Jan 1, 2014
56.87 M Stocks
Jan 1, 2015
56.87 M Stocks
Jan 1, 2016
66.69 M Stocks
Jan 1, 2017
68.28 M Stocks
Jan 1, 2018
69.38 M Stocks
Jan 1, 2019
69.63 M Stocks
Jan 1, 2020
69.94 M Stocks

Advanced Biomedical Technologies stock splits

In Advanced Biomedical Technologies's history, there have been no stock splits.
Price targets and forecasts for Advanced Biomedical Technologies are not yet available.

Advanced Biomedical Technologies shareholder structure

% Name
1.76305%
Gui (Kai)
Gui (Kai)
1.05783%
Yu (Chiming)
Yu (Chiming)

Advanced Biomedical Technologies Executives and Management Board

HW

Ms. Hui Wang

(51)

Chief Executive Officer, Director · since 2009

Compensation34,602.00 USD
KG

Mr. Kai Gui

(51)

Chief Financial Officer, Chief Operating Officer, Secretary, Director

Compensation22,950.00 USD
CY

Mr. Chiming Yu

(47)

President, Director · since 2008

Compensation15,300.00 USD
PS

Prof. Puyi Sheng

(53)

Chief Medical Officer

Compensation4,200.00 USD

Frequently asked questions about Advanced Biomedical Technologies

The business model of Advanced Biomedical Technologies Inc is focused on the development and commercialization of innovative medical devices and technologies. The company specializes in the research and production of cutting-edge healthcare solutions to improve patient outcomes. Advanced Biomedical Technologies Inc aims to capitalize on its expertise in biomaterials, bioengineering, and regenerative medicine to create high-quality products that address unmet medical needs. By leveraging its scientific knowledge and strategic partnerships, the company strives to enhance healthcare delivery and positively impact the lives of patients. Advanced Biomedical Technologies Inc is committed to advancing the field of biotechnology and revolutionizing the medical industry with its innovative products and solutions.

All fundamentals and in-depth analysis of Advanced Biomedical Technologies

Our stock analysis for Advanced Biomedical Technologies stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanced Biomedical Technologies. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Revenue→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Net Income→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies P/E→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies P/S→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies EBIT→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Dividend→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Directors Dealings→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Stocks→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Market capitalization→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Debt→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Liabilities→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Equity→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies AAQS→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Employees→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies ROE→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies ROA→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies ROCE→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies News→
Advanced Biomedical Technologies Stock
Advanced Biomedical Technologies Analyst Price Targets→

Health Stocks

Advanced Medical Solutions GroupAdvanced BiomedAdvanced Technology Co KSCPAdvagene Biopharma CoAdvantage Risk Management CoAdociaAdvicenneADMA BiologicsAdynxxAdlai Nortye Ltd. American Depositary SharesAelis FarmaAditxtAll Stocks A–Z →